Company news

Inoviq Ltd news in 2021

Inoviq Ltd's news releases, calls and decks from 2021, newest first.

View company

AGM Presentation

November 29, 2021

BARD1 Appoints New CSO

September 16, 2021

BARD1 Share Purchase Plan Completed Oversubscribed

August 22, 2021

Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer Test

August 16, 2021

BARD1 lodges spp and options prospectus

July 30, 2021

BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data

July 28, 2021

Updated Investor Presentation

July 23, 2021

BARD1 $15m Placement to Accelerate Cancer Diagnostic Program

July 22, 2021

BARD1 Investor Presentation

July 7, 2021

BARD1 Autoantibody Test Results for Ovarian Cancer Published

June 28, 2021

Update on Legal Proceedings

June 4, 2021

BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test

May 24, 2021

BARD1 EXO-NET Exosome Data Presented at ISEV2021 Conference

May 18, 2021

BARD1 Launches its RUO EXO-NET Product

May 17, 2021

Appendix 4C and Quarterly Activities Report

April 30, 2021

Positive Results from the BARD1 Autoantibody Assay

April 28, 2021

BARD1 Signs Option Agreement for Type 3C Diabetes Test

April 12, 2021

Positive Results Evaluation of EXO-NET in Pancreatic Cancer

March 15, 2021

Appendix 4D and Half-year financial report

February 26, 2021

Commencement of Legal Proceedings Against BARD1

February 23, 2021

Excellent SubB2M Breast Cancer Test Data

February 14, 2021

Outstanding SubB2M Ovarian Cancer Test Data

February 10, 2021

Decks in 2021